As of Apr 21
| -0.30 / -3.08%|
The 6 analysts offering 12-month price forecasts for Sucampo Pharmaceuticals Inc have a median target of 16.50, with a high estimate of 28.50 and a low estimate of 13.00. The median estimate represents a +74.60% increase from the last price of 9.45.
The current consensus among 6 polled investment analysts is to Buy stock in Sucampo Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.